Mark McKenna is the founder of Prometheus Biosciences. Prometheus Biosciences has raised $400M in total funding. Latest round: Series A.
Mark C. McKenna was the President and Chief Executive Officer of Prometheus Biosciences, which was acquired by Merck for $10.8 billion in April 2023. He is now the Co-founder and CEO of Mirador Therapeutics, a new biotech company focused on precision medicines for inflammatory and fibrotic diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide